Cell Therapy Technologies Global Market Sees Growth Rate Of 19% Through 2022

17 Feb, 2022

The global cell therapy technologies market size is expected to grow from $2.96 billion in 2021 to $3.52 billion in 2022 at a compound annual growth rate (CAGR) of 19.0%. The growth in the market is mainly due to an increase in investments in cell therapies and the growth in research and development for cell therapy. The cell therapy technologies market is expected to reach $6.35 billion in 2026 at a CAGR of 15.9%.

What is the Global Cell Therapy Technologies Market?

The cell therapy technologies market consists of sales of cell therapy technologies that are medicinal solutions used for developing and improving cell therapy, such as cell processing, cell banking, and point-of-care technologies. Cell therapy is a type of treatment used to inject active cells into the body of a patient for treating some disorders. This therapy seeks to treat diseases by altering certain sets of cells. In this technique, cells, which originate from the patient or a donor are modified outside the body and then injected into the patient.

Get a Sample of the global cell therapy technologies market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&&type=smp

What drives the Global Cell Therapy Technologies Market?

Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market. Governments are increasingly investing in research activities for developing therapies for diseases such as cancer, cardiovascular disease (CVD), and others. For instance, in November 2019, the Australian government released $150 million, over 10 years, for The Stem Cell Therapies Mission. The funding was obtained by Medical Research Future Fund (MRFF), to support Australian researchers to deliver new therapies. Moreover, in August 2019, Newcastle University spin-out Atelerix, pioneers in the storage and transport of cells at room temperature, were awarded a grant of £267,000 ($292,087) from Innovate UK, with collaborators Rexgenero and the cell and gene therapy catapult. Thus, the upsurge in government investments in cell-based research boosted the demand for the cell therapy technologies market in the historic period.

Get the full global cell therapy technologies industry report here:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

Global Cell Therapy Technologies Market Segments
The global cell therapy technologies market is segmented:
By Product: Consumables, Equipment, Systems and Software
By Cell Type: T-Cells, Stem Cells, Other Cells
By Process: Cell Processing, Cell Preservation, Distribution, and Handling, Process Monitoring and Quality Control
By End User: Life Science Companies, Research Institutes
By Geography: The regions covered in the cell therapy technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Cell Therapy Technologies Global Market Report 2022provides market size and growth forecasts for the global cell therapy technologies market, global cell therapy technologies market share, cell therapy technologies market segments and geographies, cell therapy technologies market competitive landscape including leading competitors’ revenues, profiles and market shares. The cell therapy technologies market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Global Cell Therapy Technologies Industry Playersinclude Thermo Fisher Scientific, Merck, MaxCyte, Lonza Group, Sartorius, Terumo BCT, Fresenius Medical Care AG & Co. KGaA, Avantor Inc., Miltenyi Biotec, STEMCELL Technologies Inc., Beckman Coulter, Danaher, Becton Dickinson and Company and GE Healthcare. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.